Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2017-06-23

Two new medicines recommended for the treatment of chronic hepatitis C

View source ↗

Summary

EMA recommended two new medicines for the treatment of chronic hepatitis C, indicating potential upcoming approvals for improved regimens.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications